Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial
Journal of Allergy and Clinical Immunology · 2025-05 · 155 (5) · 1575-1583
DOI: 10.1016/j.jaci.2025.01.034 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-05. Verfasst von Ming Zheng und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Nasal Polyps, Sinusitis, Rhinitis, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
- Department of Pathology, Beijing TongRen Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Head and Neck Molecular Pathological Diagnosis, Beijing TongRen Hospital, Capital Medical Universi…
- Department of Otolaryngology, The First People's Hospital of Foshan, Foshan, China.
- Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Otolaryngology, Head and Neck Surgery, Northern Jiangsu People's Hospital affiliated to Yangzhou University, Yangzhou, China.
- Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Zheng, M., Wu, D., Piao, Y., Tang, J., Quan, F., Guan, B., Yu, H., Zhang, X., He, G., Yang, Y., Wan, L., Li, X., Liu, W., Xu, Z., Ye, J., Liu, W., Song, X., Du, Y., Xu, Y., …, & Zhang, L. (2025). Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial. Journal of Allergy and Clinical Immunology, 155(5), 1575-1583. https://doi.org/10.1016/j.jaci.2025.01.034
Vancouver
Zheng M, Wu D, Piao Y, Tang J, Quan F, Guan B, et al. Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial. Journal of Allergy and Clinical Immunology. 2025;155(5):1575-1583. doi:10.1016/j.jaci.2025.01.034
BibTeX
@article{Zheng2025,
author = {Zheng, Ming and Wu, Di and Piao, Yingshi and Tang, Jun and Quan, Fang and Guan, Bing and Yu, Hongmeng and Zhang, Xiaowen and He, Gang and Yang, Yucheng and Wan, Lijia and Li, Xuezhong and Liu, Wen and Xu, Zhendong and Ye, Jing and Liu, Wen and Song, Xicheng and Du, Yuxiao and Xu, Yu and Chen, Jianjun and Wang, Wei and Lan, Feng and Wang, Chengshuo and Zhang, Luo},
title = {Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {155},
number = {5},
pages = {1575--1583},
doi = {10.1016/j.jaci.2025.01.034}
}
EUVIMED